Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 189-213
Closed Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 151
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 50-80
Open Access | Times Cited: 124
Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer
Marzieh Ramezani Farani, Maryam Azarian, Hamid Heydari Sheikh Hossein, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 1305-1318
Open Access | Times Cited: 89
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 74
Curcumin: An epigenetic regulator and its application in cancer
Tianqi Ming, Tao Qiu, Shun Tang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113956-113956
Closed Access | Times Cited: 72
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis
Hardeep Singh Tuli, Jagjit Kaur, Kanupriya Vashishth, et al.
Archives of Toxicology (2022) Vol. 97, Iss. 1, pp. 103-120
Closed Access | Times Cited: 57
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression
Milad Ashrafizadeh, Navid Rabiee, Alan Prem Kumar, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2181-2198
Closed Access | Times Cited: 56
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences (2022) Vol. 298, pp. 120463-120463
Open Access | Times Cited: 51
Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma
Yongshun Zheng, Ran Jia, Jun Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 49
Plants as a Source of Anticancer Agents: From Bench to Bedside
Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4818-4818
Open Access | Times Cited: 46
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 40
Non-coding RNAs and macrophage interaction in tumor progression
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
NF-κB inhibitors gifted by nature: The anticancer promise of polyphenol compounds
Chengcheng Guan, Xintong Zhou, Huayao Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113951-113951
Open Access | Times Cited: 39
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
Mian Huang, Bingtao Zhai, Yu Fan, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4275-4311
Open Access | Times Cited: 39
Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways
Eisa Sabouni, Melina Maghsodlou Nejad, Sarah Mojtabavi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114395-114395
Open Access | Times Cited: 38
Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal
Suneel Kumar, Stephen O. Mathew, Ravindra Prasad Aharwal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 160-160
Open Access | Times Cited: 33
The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
Mohamed J. Saadh, Hala Baher, Yuanji Li, et al.
Environmental Research (2023) Vol. 233, pp. 116490-116490
Closed Access | Times Cited: 32
Graphene Oxide-Functionalized Bacterial Cellulose–Gelatin Hydrogel with Curcumin Release and Kinetics: In Vitro Biological Evaluation
Muhammad Umar Aslam Khan, Goran Stojanović, Roselinda Ab Rehman, et al.
ACS Omega (2023) Vol. 8, Iss. 43, pp. 40024-40035
Open Access | Times Cited: 31
Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines
Chong Qiu, Jun Zhe Zhang, Bo Wu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2023) Vol. 232, pp. 123377-123377
Closed Access | Times Cited: 25
Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms
Rekha Gahtori, Ankita Tripathi, Amrita Kumari, et al.
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Malignant function of nuclear factor-kappaB axis in prostate cancer: Molecular interactions and regulation by non-coding RNAs
Reyadh R. Al‐Rashidi, Sara Abdalrazzaq M. Noraldeen, Ali Kamil Kareem, et al.
Pharmacological Research (2023) Vol. 194, pp. 106775-106775
Open Access | Times Cited: 23
Natural products reverse cancer multidrug resistance
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 14
Hyaluronic Acid – Coated Niosomes for Curcumin Targeted Delivery into Breast Cancer Cells
Zahraa M. Al Zubaidi, Hamdi Nsairat, Naeem Shalan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 3
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top